Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Part of paid clinical trials in Englewood, New Jersey.

Sponsor
Englewood Hospital and Medical Center
Study ID
NCT06681818
Status
Recruiting

Conditions

  • Liver Cancer Adult
  • Liver Regeneration

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • carbon monoxide measurement via smokerlyzer — OTHER
    participants in this study will provide breath samples for carbon monoxide measurements pre and post liver resection

Study Details

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Key Dates

Start date
Nov 21, 2025
Status verified
Nov 2024
Primary completion
Jan 1, 2039
Completion
Jan 1, 2039

Study Design

Enrollment
125 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: all participants
    all participants will provide breath samples to detect carbon monoxide levels

Primary Outcome Measure

correlation of carbon monoxide levels in exhaled breath with quantity and quality of liver regeneration [ Time Frame: measurements will be taken pre, then 4 hours and 24 hours post resection ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Englewood HospitalEnglewoodNew Jersey07631
Jamie Ketas
2018943418
Raquel Molina

Find similar trials in Englewood, NJ